
Number of publications published per year by Baumgarten, Axel. (Source : PubMed)

Distribution of publications types for Baumgarten, Axel. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Efficacy and tolerability of peginterferon alfa-2a or alfa-2b plus ribavirin in the daily routine treatment of patients with chronic hepatitis C in Germany: The PRACTICE Study.
J. Viral Hepat.
2010

Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection.
Clin. Infect. Dis.
2009;49;2


Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men.
Gastroenterology
2009;136;5

Epidemiologically linked transmission of HIV-1 illustrates the impact of host genetics on virological outcome.
AIDS
2009;23;2
The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells.
Oncogene
2008;27;7

[Smoking behavior during pregnancy of women with type 1 or gestational diabetes]
Dtsch. Med. Wochenschr.
2007;132;21
N-terminal pro-B-type natriuretic peptide (NT-proBNP) in HIV-1 infected individuals on HAART.
Eur. J. Med. Res.
2007;12;4
Predictors of postpartum diabetes in women with gestational diabetes mellitus.
Diabetes
2006;55;3


Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals.
Antivir. Ther. (Lond.)
2006;11;8
Neonatal Bacille Calmette-Guerin vaccination and type 1 diabetes.
Diabetes Care
2005;28;5
[ See timeline ] [ See all publications ]
means that Baumgarten, Axel has 9 papers cited a least 9 times - methodology
Institut für Diabetesforschung, München, Germany.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.